H-Arg-Gly-Tyr-Ala-Leu-Gly-OH
H-Arg-Gly-Tyr-Ala-Leu-Gly-OH is a competitive and CAMP dependent protein kinase inhibitor[1].
Product Specifications
CAS Number
59587-24-5
UNSPSC
12352209
Target
PKA; PKC
Type
Peptides
Related Pathways
Epigenetics; Stem Cell/Wnt; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/h-arg-gly-tyr-ala-leu-gly-oh.html
Solubility
10 mM in DMSO
Smiles
O=C(O)CNC([C@H](CC(C)C)NC([C@H](C)NC([C@H](CC1=CC=C(O)C=C1)NC(CNC([C@H](CCCNC(N)=N)N)=O)=O)=O)=O)=O
Molecular Formula
C28H45N9O8
Molecular Weight
635.71
References & Citations
[1]Kemp BE, et al. Synthetic hexapeptide substrates and inhibitors of 3':5'-cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1976 Apr;73 (4) :1038-42.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740630-500 1x 500 µL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471718-100 1x 100 µL
Bcl-6 (Follicular Lymphoma Marker) (BCL6/1718), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040956-100 1x 100 µL
UACA / Nucling (AE-5), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details